| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |